Fin Trust Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Fin Trust Capital Advisors, LLC

$525 Million
Q2 2024

A detailed history of Fin Trust Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 20,366 shares of BMY stock, worth $1.04 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

20,366

Previous 27,090 24.82%

Holding current value

$1.04 Million

Previous $1.47 Million 42.48%

% of portfolio

0.16%

Previous 0.29%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$40.25 - $52.99 $270,641 - $356,304	-6,724 Reduced 24.82%	20,366 $845,000
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $52,873 - $59,948	-1,102 Reduced 3.91%	27,090 $1.47 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1.31 Million - $1.56 Million	-26,924 Reduced 48.85%	28,192 $1.45 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $157,113 - $175,677	2,714 Added 5.18%	55,116 $3.2 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $796,901 - $943,644	-11,637 Reduced 18.17%	52,402 $3.77 Million
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $38 - $22,744	-296 Reduced 0.46%	64,039 $4.59 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $90,048 - $99,175	-1,240 Reduced 1.89%	64,335 $4.72 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $1.17 Million - $1.4 Million	18,998 Added 40.79%	65,575 $4.79 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.61 Million - $1.88 Million	30,077 Added 182.28%	46,577 $2.9 Million
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $1.7 Million - $1.99 Million	-28,663 Reduced 63.47%	16,500 $976,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $109,209 - $118,928	1,764 Added 4.06%	45,163 $3.02 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $421,670 - $474,254	7,106 Added 19.58%	43,399 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $165,540 - $187,587	2,867 Added 8.58%	36,293 $2.25 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $57,774 - $64,021	-1,006 Reduced 2.92%	33,426 $2.02 Million
Q2 2020 Sep 11, 2020	BUY	$54.82 - $64.09 $1.61 Million - $1.89 Million	29,432 Added 588.64%	34,432 $2.03 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $586,080 - $685,186	-10,691 Reduced 68.13%	5,000 $294,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $89,691 - $130,342	1,933 Added 14.05%	15,691 $875,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $423,648 - $552,611	8,609 Added 167.2%	13,758 $883,000
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $85 - $101	2 Added 0.04%	5,149 $261,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $4,060 - $4,489	-91 Reduced 1.74%	5,147 $233,000
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $29,553 - $35,239	655 Added 14.29%	5,238 $250,000
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $223,467 - $289,783	4,583 New	4,583 $238,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.

Account

Fin Trust Capital Advisors, LLC Bristol Myers Squibb CO Transaction History